3,4-Methylenedioxy-N-hydroxyamphetamine (MDOH, MDH), also known as N-hydroxy-MDA, is an entactogen, psychedelic, and stimulant of the phenethylamine, amphetamine, and MDxx families. It is the N-hydroxy homologue of MDA, and the N-desmethyl homologue of FLEA (MDMOH).
Use and effects In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin listed the dose range as 100 to 160mg orally and its duration as approximately 3 to 6hours. He describes MDOH as being very psychedelic and producing increased pleasure in beauty and nature. Shulgin also mentioned several negative side effects also seen with MDMA ("Ecstasy") such as difficulty urinating and internal dryness. He has noted that the properties and effects of MDOH are very similar or near-identical to those of MDA and that MDOH might be converted into MDA in the body.
Interactions
Chemistry Synthesis The chemical synthesis of MDOH has been described.
Analogues Analogues of MDOH include MDA and FLEA (MDMOH), among others.
Society and culture Legal status Canada MDOH is a controlled substance in Canada.
United States MDOH is a schedule I controlled substance in the United States.
See also Substituted methylenedioxyphenethylamine HOT-x (psychedelics) N-Hydroxyamphetamine N-Hydroxy-DOM N-Hydroxy-AMT
References
External links MDOH - Isomer Design MDOH - PiHKAL - Erowid MDOH - PiHKAL - Isomer Design